1) Ansseau M, De Roeck J:Trazodone in benzodiazepine dependence. J Clin Psychiatry 54:189-191, 1993
2) 井澤志名野,早川達郎,和田清:ベンゾジアゼピン系薬物の使用原則と臨床容量依存の診断と治療.白倉克之,樋口進,和田清 編,アルコール・薬物関連障害の診断・治療ガイドライン.じほう,pp207-222,2003
3) 井澤志名野,松村光邦:ベンゾジアゼピン臨床容量依存と退薬症候の治療.臨精薬理 6:1161-1168, 2003
4) Kaendler SH, Volk S, Pflug B:Benzodiazepine withdrawal with carbamazepine. Nervenarzt 67:381-386, 1996
5) 川上さやか,山口直明,宮坂佳幸,他:トリアゾラム臨床用量依存高齢者の1例.老年精医誌 20:892-894, 2009
6) Kroeze WK, Hufeisen SJ, Popadak BA, et al:H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs. Neuropsychopharmacology 28:519-526, 2003
7) Rickels K, Case WG, Schweizer E, et al:Benzodiazepine dependence:management of discontinuation. Psychopharmacol Bull 26:63-68, 1990
8) Rickels K, Schweizer E, Garcia España F, et al:Trazodone and valproate in patients discontinuing long-term benzodiazepine therapy:Effects on withdrawal symptoms and taper outcome. Psychopharmacology(Berl) 141:1-5, 1999
9) Sim M:Drug addiction and the hallucinogens. In:Sim M ed. Guide to Psychiatry, 3rd ed. Churchill Livingstone, London, pp360-395, 1974
10) 鈴木博子,木村真人,森隆夫:睡眠薬依存症.精神科治療学 14:293-299, 1999
11) Wallis R:Potentiation of hypnotics and analgesics;Clinical experience with chlorpromazine. New York State J Med 55:243-245, 1955